Article

Akorn launches generic antibiotic formulations

Buffalo Grove, IL—Now that patents have expired on two popular antibiotics, Akorn Inc. has launched generic versions of Alcon's Ciloxan and Ocuflox.

Buffalo Grove, IL-Now that patents have expired on two popular antibiotics, Akorn Inc. has launched generic versions of Alcon's Ciloxan and Ocuflox.

Ciprofloxacin ophthalmic solutions USP, 0.3%, and ofloxacin ophthalmic solution USP, 0.3%, were launched in the U.S. market in May. The company anticipates the combined market potential for both products to be more than $40 million.

The new products will be marketed through the company's existing distribution channels.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.